Herd immunity is a key concept for epidemic control, which states that only a proportion of a population needs to be immune to an infectious agent for it to stop generating large outbreaks. We can achieve herd immunity through two strategies: by overcoming natural infection or through vaccination.
This is the summary of the article “COVID-19 herd immunity: Where are we?” published in Nature Reviews Immunology on 9th Sept 2020.
Authors of this article Arnaud Fontanet & Simon Cauchemez state that there is little evidence to suggest that the spread of SARS-CoV-2 might stop naturally before at least 50% of the population has become immune.
So, what would it take to achieve 50% population immunity?
- One of the main problems is we currently do not know how long the naturally acquired immunity to SARS-CoV-2 lasts. The duration of immunity is particularly of concern among those who had mild forms of Covid-19. If we take seasonal coronaviruses as the benchmark, they usually have short-lived immunity.
- We should also check whether it might take several rounds of re-infection before robust immunity is attained against SARS-COV-2. With flu pandemics, herd immunity is usually attained after two to three epidemic waves.
- The cost of reaching herd immunity through natural infection would be very high, especially among individuals who are at a higher risk of developing severe complications. That’s why an effective vaccine presents the safest way to reach herd immunity.
As of August 2020, six anti-SARS-CoV-2 vaccines have reached phase III trials. We can assume that some will become available by early 2021, although their safety and efficacy remain to be established. We wait for further evidence.
Click here to read the full article.
Tags:
Although most individuals recover completely from COVID-19 within a few weeks, some continue to experience symptoms after their initial recovery — even ...
Antibody testing among vaccine beneficiaries has increased manifold recently due to the anxiety over post-vaccination immunity, but are these antibody tests...
The AI Index is recognized globally as one of the most credible and authoritative sources for data and insights on artificial intelligence (AI). The AI ...
LONDON, UK/CHENNAI, India: UK Research and Innovation and India’s Department of Biotechnology in the Ministry of Science and Technology have recently ...
Mind your mind because a dilapidated one is worse than having none. Dr. Bhavdeep Singh Ahuja emphasizes the importance of mental health in these challenging...
The World Health Organization (WHO) panel, in its latest statement, has recommended against the use of the remdesivir, an antiviral drug, in hospitalized ...
With newer variants emerging and challenging our previously acquired immunity and creating worldwide uncertainty, there is an urgent need for antiviral ...
Information on the transmission of the SARS-CoV-2 virus has constantly been evolving right from droplet spread to the virus being declared airborne. The ...
So far, the COVID-19 management has mainly focused on pneumonia and blood clots. Now evidence is building up on how COVID-19 recovered individuals can ...
The ITI India Congress 2023, hosted by the ITI Leadership Team India and Straumann India at the Grand Sheraton, Bangalore on the 25-26 of November 2023, was...
Live webinar
Fri. 19 July 2024
5:30 am IST (New Delhi)
Live webinar
Wed. 7 August 2024
3:30 am IST (New Delhi)
Live webinar
Wed. 14 August 2024
4:30 am IST (New Delhi)
Live webinar
Wed. 21 August 2024
6:30 pm IST (New Delhi)
Dr. Jim Lai DMD, MSc(Perio), EdD, FRCD(C)
Live webinar
Thu. 29 August 2024
5:30 am IST (New Delhi)
Live webinar
Mon. 2 September 2024
2:30 pm IST (New Delhi)
Live webinar
Tue. 3 September 2024
8:30 pm IST (New Delhi)
To post a reply please login or register